30
Participants
Start Date
April 30, 2013
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
Sorafenib
Doxorubicin
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center, Sleepy Hollow
Memorial Sloan Kettering West Harrison, Harrison
Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack
Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge
Collaborators (1)
Bayer
INDUSTRY
National Comprehensive Cancer Network
NETWORK
Memorial Sloan Kettering Cancer Center
OTHER